View Past PerformanceBIO-key International バランスシートの健全性財務の健全性 基準チェック /36BIO-key Internationalの総株主資本は$7.7M 、総負債は$654.6Kで、負債比率は8.5%となります。総資産と総負債はそれぞれ$10.9Mと$3.2Mです。主要情報8.54%負債資本比率US$654.63k負債インタレスト・カバレッジ・レシオn/a現金US$2.69mエクイティUS$7.67m負債合計US$3.20m総資産US$10.87m財務の健全性に関する最新情報BIO-Key International, Inc. Receives Notice of Non-Compliance from Nasdaq Related to Delay of Its Form 10-K FilingApr 23BIO-key International, Inc. announced delayed annual 10-K filingApr 01Bio-Key International, Inc. Receives Notice of Nasdaq Continued Listing Compliance Period for Minimum Bid PriceNov 08+ 1 more updateBIO-key International, Inc. announced delayed annual 10-K filingApr 02BIO-key International (NASDAQ:BKYI) Is Carrying A Fair Bit Of DebtJan 01BIO-key International, Inc. Receives Non-Compliance Letter Regarding Nasdaq Listing Rule 5550(b)(1)Jun 15+ 2 more updatesすべての更新を表示Recent updatesBIO-Key International, Inc. Receives Notice of Non-Compliance from Nasdaq Related to Delay of Its Form 10-K FilingApr 23BIO-key International, Inc. announced delayed annual 10-K filingApr 01BIO-key International, Inc. Provides Earnings Guidance for the First Quarter of 2026Mar 31BIO-key International, Inc. to Report Fiscal Year 2025 Results on Mar 31, 2026Mar 26New major risk - Financial position Nov 23Third quarter 2025 earnings released: US$0.15 loss per share (vs US$0.39 loss in 3Q 2024) Nov 16BIO-key International, Inc. provides earnings guidance for the year 2025 and 2026Nov 14BIO-Key Showcases Biometric Identity Innovations At Africa Tech Festival 2025Nov 10Bio-Key International, Inc. Receives Notice of Nasdaq Continued Listing Compliance Period for Minimum Bid PriceNov 08+ 1 more updateBIO-key Introduces EcoID III USB Fingerprint Scanner Delivering FBI FAP 20 Certification, Security, Liveness Detection, and Encrypted Device-to-Host CommunicationOct 22BIO-key Showcases Next-Generation Identity & Biometric Authentication Solutions At Premier Tech and Cybersecurity Events: GITEX 2025 in Dubai and 19ENISE in SpainOct 15Second quarter 2025 earnings released: US$0.20 loss per share (vs US$1.00 loss in 2Q 2024) Aug 14BIO-key International, Inc. to Report Q2, 2025 Results on Aug 13, 2025Aug 05We Think The Compensation For BIO-key International, Inc.'s (NASDAQ:BKYI) CEO Looks About RightAug 01Price target decreased by 60% to US$2.00 Jul 01BIO-key International, Inc., Annual General Meeting, Aug 08, 2025Jun 30BIO-key International, Inc. to Report Q1, 2025 Results on May 16, 2025May 09BIO-key International, Inc. announced delayed annual 10-K filingApr 02Full year 2024 earnings released: US$2.10 loss per share (vs US$15.21 loss in FY 2023) Mar 28BIO-key International, Inc. to Report Q4, 2024 Results on Mar 27, 2025Mar 20BIO-key International (NASDAQ:BKYI) Is Carrying A Fair Bit Of DebtJan 01Third quarter 2024 earnings released: US$0.39 loss per share (vs US$1.26 loss in 3Q 2023) Nov 17BIO-key International, Inc. Provides Revenues Guidance for the Year 2024Nov 15BIO-key International, Inc. to Report Q3, 2024 Results on Nov 14, 2024Nov 07Price target decreased by 40% to US$3.00 Aug 16BIO-key®International, Inc.'s PortalGuard Identity and Access Management Solution and Identity-Bound Biometrics Now Available on the Amazon Web Services MarketplaceAug 15BIO-key International, Inc. to Report Q2, 2024 Results on Aug 14, 2024Aug 12BIO-key International, Inc., Annual General Meeting, Aug 22, 2024Jul 11BIO-key International, Inc. Receives Non-Compliance Letter Regarding Nasdaq Listing Rule 5550(b)(1)Jun 15+ 2 more updatesBIO-key International, Inc. announced delayed 10-Q filingMay 18BIO-key International, Inc. announced delayed annual 10-K filingApr 03BIO-key International, Inc. to Report Q4, 2023 Results on Apr 02, 2024Mar 28Forecast to breakeven in 2024 Feb 15BIO-key International, Inc. announced that it has received $0.547726 million in funding from Dillon Hill Capital, LLCDec 22BIO-key International, Inc. announced delayed 10-Q filingNov 17BIO-key International, Inc. Announces Resignation of Thomas E. Bush, III From the Board of DirectorsNov 15Price target decreased by 25% to US$1.50 Nov 15BIO-key International, Inc. has completed a Composite Units Offering in the amount of $3.75025 million.Nov 02BIO-key International, Inc. announced delayed 10-Q filingAug 17Price target decreased by 60% to US$2.00 Aug 16BIO-key International, Inc. to Report Q2, 2023 Results on Aug 14, 2023Aug 08BIO-Key International Receives a Letter from NasdaqJul 16BIO-key Regains Compliance with Nasdaq Rule Requiring Timely Filing of Periodic Financial Reports Following Filing of its First Quarter 2023 Form 10-Q with SECJun 14BIO-key International, Inc., Annual General Meeting, Jul 24, 2023Jun 10Bio-Key International, Inc. Appoints Cameron E. Williams to Its Board of DirectorsJun 03BIO-key International Receives Notice of Non-Compliance from NasdaqMay 31BIO-key International, Inc. announced delayed 10-Q filingMay 17First quarter 2023 earnings released: US$0.057 loss per share (vs US$0.13 loss in 1Q 2022) May 16BIO-key International, Inc. to Report Q1, 2023 Results on May 15, 2023May 09Insufficient new directors May 01BIO-key International, Inc. Announces Thomas Gilley to Resign from the Board of DirectorsFeb 18BIO-key Receives Nasdaq Notification Regarding $1.00 Minimum Closing Bid Price RequirementJan 16Bio-Key International, Inc Announces Anticipation of the Planned Retirement of Fred Corsentino, Chief Revenue OfficerJan 04Price target decreased to US$4.00 Nov 16Insufficient new directors Nov 16Insufficient new directors Aug 16BIO-key GAAP EPS of -$0.21, revenue of $1.9M Aug 12Full year 2021 earnings released: US$0.65 loss per share (vs US$2.08 loss in FY 2020) Mar 30Insufficient new directors Dec 05No longer forecast to breakeven Nov 25Third quarter 2021 earnings released: US$0.13 loss per share (vs US$0.51 loss in 3Q 2020) Nov 18Forecast to breakeven in 2022 Sep 23Second quarter 2021 earnings released: US$0.15 loss per share (vs US$0.60 loss in 2Q 2020) Aug 18Here's Why Shareholders May Want To Be Cautious With Increasing BIO-key International, Inc.'s (NASDAQ:BKYI) CEO Pay PacketJun 12First quarter 2021 earnings released: US$0.094 loss per share (vs US$1.84 loss in 1Q 2020) May 16財務状況分析短期負債: BKYIの 短期資産 ( $4.6M ) が 短期負債 ( $3.1M ) を超えています。長期負債: BKYIの短期資産 ( $4.6M ) が 長期負債 ( $100.4K ) を上回っています。デット・ツー・エクイティの歴史と分析負債レベル: BKYI総負債よりも多くの現金を保有しています。負債の削減: BKYIの負債対資本比率は、過去 5 年間で1.1%から8.5%に増加しました。貸借対照表キャッシュ・ランウェイ分析過去に平均して赤字であった企業については、少なくとも1年間のキャッシュ・ランウェイがあるかどうかを評価する。安定したキャッシュランウェイ: BKYIは、現在の フリーキャッシュフロー に基づくと、キャッシュランウェイ が 1 年未満です。キャッシュランウェイの予測: フリーキャッシュフローが毎年5.9 % の歴史的率で成長し続ける場合、 BKYIのキャッシュランウェイは 1 年未満になります。健全な企業の発掘7D1Y7D1Y7D1YSoftware 業界の健全な企業。View Dividend企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/04/30 10:34終値2026/04/30 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋BIO-key International, Inc. 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Jack Vander AardeMaxim Group
BIO-Key International, Inc. Receives Notice of Non-Compliance from Nasdaq Related to Delay of Its Form 10-K FilingApr 23
Bio-Key International, Inc. Receives Notice of Nasdaq Continued Listing Compliance Period for Minimum Bid PriceNov 08+ 1 more update
BIO-key International, Inc. Receives Non-Compliance Letter Regarding Nasdaq Listing Rule 5550(b)(1)Jun 15+ 2 more updates
BIO-Key International, Inc. Receives Notice of Non-Compliance from Nasdaq Related to Delay of Its Form 10-K FilingApr 23
Bio-Key International, Inc. Receives Notice of Nasdaq Continued Listing Compliance Period for Minimum Bid PriceNov 08+ 1 more update
BIO-key Introduces EcoID III USB Fingerprint Scanner Delivering FBI FAP 20 Certification, Security, Liveness Detection, and Encrypted Device-to-Host CommunicationOct 22
BIO-key Showcases Next-Generation Identity & Biometric Authentication Solutions At Premier Tech and Cybersecurity Events: GITEX 2025 in Dubai and 19ENISE in SpainOct 15
We Think The Compensation For BIO-key International, Inc.'s (NASDAQ:BKYI) CEO Looks About RightAug 01
BIO-key®International, Inc.'s PortalGuard Identity and Access Management Solution and Identity-Bound Biometrics Now Available on the Amazon Web Services MarketplaceAug 15
BIO-key International, Inc. Receives Non-Compliance Letter Regarding Nasdaq Listing Rule 5550(b)(1)Jun 15+ 2 more updates
BIO-key International, Inc. announced that it has received $0.547726 million in funding from Dillon Hill Capital, LLCDec 22
BIO-key International, Inc. Announces Resignation of Thomas E. Bush, III From the Board of DirectorsNov 15
BIO-key International, Inc. has completed a Composite Units Offering in the amount of $3.75025 million.Nov 02
BIO-key Regains Compliance with Nasdaq Rule Requiring Timely Filing of Periodic Financial Reports Following Filing of its First Quarter 2023 Form 10-Q with SECJun 14
Bio-Key International, Inc Announces Anticipation of the Planned Retirement of Fred Corsentino, Chief Revenue OfficerJan 04
Here's Why Shareholders May Want To Be Cautious With Increasing BIO-key International, Inc.'s (NASDAQ:BKYI) CEO Pay PacketJun 12
